| Title |
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer
|
|---|---|
| Published in |
SpringerPlus, May 2014
|
| DOI | 10.1186/2193-1801-3-244 |
| Pubmed ID | |
| Authors |
Sara A Hurvitz, Linda D Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass, Frederick P Smith, Gladys I Rodriguez, Barrett H Childs, Dennis J Slamon |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 25 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 36% |
| Student > Master | 5 | 20% |
| Student > Ph. D. Student | 3 | 12% |
| Other | 2 | 8% |
| Student > Postgraduate | 2 | 8% |
| Other | 3 | 12% |
| Unknown | 1 | 4% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 36% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 16% |
| Agricultural and Biological Sciences | 2 | 8% |
| Psychology | 2 | 8% |
| Biochemistry, Genetics and Molecular Biology | 1 | 4% |
| Other | 4 | 16% |
| Unknown | 3 | 12% |